Open Access

Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax

  • Authors:
    • Yu Fan
    • Yu Wang
    • Shaozhi Fu
    • Duan Liu
    • Sheng Lin
  • View Affiliations

  • Published online on: July 5, 2019     https://doi.org/10.3892/etm.2019.7737
  • Pages: 1563-1570
  • Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The Krüppel‑associated box zinc‑finger protein 545 (ZNF545) was recently identified as a tumor suppressor in esophageal squamous cell carcinoma (ESCC). However, the role of ZNF545 in the tumorigenesis of esophageal cancer cells expressing loss‑of‑function mutant p53 has not been elucidated. In the present study, the role of ZNF545 in esophageal tumors and the p53‑mutant ESCC cell line, KYSE150, was investigated. ZNF545 mRNA was significantly downregulated in tumors when compared with adjacent normal tissues. Methylated ZNF545 was detected in 76.6% of tumor tissues compared with 28.1% of adjacent normal tissues. Combined pharmacological treatment of KYSE150 cells with a demethylating reagent and deacetylase inhibitor restored the expression of ZNF545. Ectopic expression of ZNF545 activated p53 transcription and upregulated the protein expression levels of pivotal effectors p21 and Bax, which are associated with cell proliferation and apoptosis, respectively, in p53‑mutant KYSE150 cells; while suppressing colony formation and inducing apoptosis. ZNF545 was therefore proposed as a potential tumor suppressor responsible for inhibiting the growth of p53‑mutant ESCC cell lines. In addition, tumor‑specific methylation of ZNF545 may represent an epigenetic diagnostic biomarker and a therapeutic target in patients with esophageal cancer.

References

1 

Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, et al: International cancer seminars: A focus on esophageal squamous cell carcinoma. Ann Oncol. 28:2086–2093. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Abnet CC, Arnold M and Wei WQ: Epidemiology of esophageal squamous cell carcinoma. Gastroenterology. 154:360–373. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Holubekova V, Mendelova A, Jasek K, Mersakova S, Zubor P and Lasabova Z: Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncol. 13:2217–2222. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Cheng Y, Liang P, Geng H, Wang Z, Li L, Cheng SH, Ying J, Su X, Ng KM, Ng MH, et al: A novel 19q13 nucleolar zinc finger protein suppresses tumor cell growth through inhibiting ribosome biogenesis and inducing apoptosis but is frequently silenced in multiple carcinomas. Mol Cancer Res. 10:925–936. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Ye L, Xiang T, Fan Y, Zhang D, Li L, Zhang C, He X, Xiang Q, Tao Q and Ren G: The 19q13 KRAB Zinc-finger protein ZFP82 suppresses the growth and invasion of esophageal carcinoma cells through inhibiting NF-κB transcription and inducing apoptosis. Epigenomics. 11:65–80. 2019. View Article : Google Scholar : PubMed/NCBI

6 

Fan Y, Zhan Q, Xu H, Li L, Li C, Xiao Q, Xiang S, Hui T, Xiang T and Ren G: Epigenetic identification of ZNF545 as a functional tumor suppressor in multiple myeloma via activation of p53 signaling pathway. Biochem Biophys Res Commun. 474:660–666. 2016. View Article : Google Scholar : PubMed/NCBI

7 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

8 

Tao Q, Huang H, Geiman TM, Lim CY, Fu L, Qiu GH and Robertson KD: Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet. 11:2091–2102. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Wang S, Cheng Y, Du W, Lu L, Zhou L, Wang H, Kang W, Li X, Tao Q, Sung JJ and Yu J: Zinc-finger protein 545 is a novel tumour suppressor that acts by inhibiting ribosomal RNA transcription in gastric cancer. Gut. 62:833–841. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Xiao Y, Xiang T, Luo X, Li C, Li Q, Peng W, Li L, Li S, Wang Z, Tang L, et al: Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer. PLoS One. 9:e1109902014. View Article : Google Scholar : PubMed/NCBI

11 

Herman JG and Baylin SB: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Deng J, Liang H, Ying G, Dong Q, Zhang R, Yu J, Fan D and Hao X: Poor survival is associated with the methylated degree of zinc-finger protein 545 (ZNF545) DNA promoter in gastric cancer. Oncotarget. 6:4482–4495. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Yu J, Li X, Tao Q, Yu XL, Cheng ZG, Han ZY, Guo M and Liang P: Hypermethylation of ZNF545 is associated with poor prognosis in patients with early-stage hepatocellular carcinoma after thermal ablation. Gut. 64:1836–1837. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Kaiser AM and Attardi LD: Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death Differ. 25:93–103. 2018. View Article : Google Scholar : PubMed/NCBI

15 

Shu KX, Li B and Wu LX: The p53 network: P53 and its downstream genes. Colloids Surf B Biointerfaces. 55:10–18. 2007. View Article : Google Scholar : PubMed/NCBI

16 

Ozaki T, Nakagawara A and Nagase H: RUNX Family participates in the regulation of p53-dependent DNA damage response. Int J Genomics. 2013:2713472013. View Article : Google Scholar : PubMed/NCBI

17 

Yang M, Wu S, Su X and May WS: JAZ mediates G1 cell-cycle arrest and apoptosis by positively regulating p53 transcriptional activity. Blood. 108:4136–4145. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Gottlieb TM, Leal JF, Seger R, Taya Y and Oren M: Cross-talk between Akt, p53 and Mdm2: Possible implications for the regulation of apoptosis. Oncogene. 21:1299–1303. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Janicke RU, Sohn D and Schulze-Osthoff K: The dark side of a tumor suppressor: Anti-apoptotic p53. Cell Death Differ. 15:959–976. 2008. View Article : Google Scholar : PubMed/NCBI

20 

Zhao D, Tahaney WM, Mazumdar A, Savage MI and Brown PH: Molecularly targeted therapies for p53-mutant cancers. Cell Mol Life Sci. 74:4171–4187. 2017. View Article : Google Scholar : PubMed/NCBI

21 

Andries V, Vandepoele K, Staes K, Berx G, Bogaert P, Van Isterdael G, Ginneberge D, Parthoens E, Vandenbussche J, Gevaert K and van Roy F: NBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest. BMC Cancer. 15:3912015. View Article : Google Scholar : PubMed/NCBI

22 

Mirzayans R, Andrais B, Kumar P and Murray D: Significance of Wild-type p53 signaling in suppressing apoptosis in response to chemical genotoxic agents: Impact on chemotherapy outcome. Int J Mol Sci. 18(pii): E9282017. View Article : Google Scholar : PubMed/NCBI

23 

Selivanova G and Wiman KG: Reactivation of mutant p53: Molecular mechanisms and therapeutic potential. Oncogene. 26:2243–2254. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Basile JR, Eichten A, Zacny V and Münger K: NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol Cancer Res. 1:262–270. 2003.PubMed/NCBI

Related Articles

Journal Cover

September 2019
Volume 18 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Fan, Y., Wang, Y., Fu, S., Liu, D., & Lin, S. (2019). Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax. Experimental and Therapeutic Medicine, 18, 1563-1570. https://doi.org/10.3892/etm.2019.7737
MLA
Fan, Y., Wang, Y., Fu, S., Liu, D., Lin, S."Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax". Experimental and Therapeutic Medicine 18.3 (2019): 1563-1570.
Chicago
Fan, Y., Wang, Y., Fu, S., Liu, D., Lin, S."Methylation‑regulated ZNF545 inhibits growth of the p53‑mutant KYSE150 cell line by inducing p21 and Bax". Experimental and Therapeutic Medicine 18, no. 3 (2019): 1563-1570. https://doi.org/10.3892/etm.2019.7737